• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Neu原癌基因产物与转化生长因子α在转基因小鼠乳腺上皮中的协同相互作用。

Synergistic interaction of the Neu proto-oncogene product and transforming growth factor alpha in the mammary epithelium of transgenic mice.

作者信息

Muller W J, Arteaga C L, Muthuswamy S K, Siegel P M, Webster M A, Cardiff R D, Meise K S, Li F, Halter S A, Coffey R J

机构信息

Institute for Molecular Biology and Biotechnology, McMaster University, Hamilton, Ontario, Canada.

出版信息

Mol Cell Biol. 1996 Oct;16(10):5726-36. doi: 10.1128/MCB.16.10.5726.

DOI:10.1128/MCB.16.10.5726
PMID:8816486
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC231573/
Abstract

Transgenic mice expressing either the neu proto-oncogene or transforming growth factor (TGF-alpha) in the mammary epithelium develop spontaneous focal mammary tumors that occur after a long latency. Since the epidermal growth factor receptor (EGFR) and Neu are capable of forming heterodimers that are responsive to EGFR ligands such as TGF-alpha, we examined whether coexpression of TGF-alpha and Neu in mammary epithelium could cooperate to accelerate the onset of mammary tumors. To test this hypothesis, we interbred separate transgenic strains harboring either a mouse mammary tumor virus/TGF-alpha or a mouse mammary tumor virus/neu transgene to generate bitransgenic mice that coexpress TGF-alpha and neu in the mammary epithelium. Female mice coexpressing TGF-alpha and neu developed multifocal mammary tumors which arose after a significantly shorter latency period than either parental strain alone. The development of these mammary tumors was correlated with the tyrosine phosphorylation of Neu and the recruitment of c-Src to the Neu complex. Immunoprecipitation and immunoblot analyses with EGFR- and Neu-specific antisera, however, failed to detect physical complexes of these two receptors. Taken together, these observations suggest that Neu and TGF-alpha cooperate in mammary tumorigenesis through a mechanism involving Neu and EGFR transactivation.

摘要

在乳腺上皮中表达神经原癌基因或转化生长因子(TGF-α)的转基因小鼠会发生自发性局灶性乳腺肿瘤,且潜伏期较长。由于表皮生长因子受体(EGFR)和Neu能够形成对诸如TGF-α等EGFR配体有反应的异二聚体,我们研究了TGF-α和Neu在乳腺上皮中的共表达是否会协同作用以加速乳腺肿瘤的发生。为了验证这一假设,我们将分别携带小鼠乳腺肿瘤病毒/TGF-α或小鼠乳腺肿瘤病毒/neu转基因的不同转基因品系进行杂交,以产生在乳腺上皮中共表达TGF-α和neu的双转基因小鼠。共表达TGF-α和neu的雌性小鼠发生了多灶性乳腺肿瘤,其出现的潜伏期明显短于单独的亲本品系。这些乳腺肿瘤的发生与Neu的酪氨酸磷酸化以及c-Src向Neu复合物的募集相关。然而,用EGFR和Neu特异性抗血清进行免疫沉淀和免疫印迹分析未能检测到这两种受体的物理复合物。综上所述,这些观察结果表明Neu和TGF-α通过涉及Neu和EGFR反式激活的机制在乳腺肿瘤发生过程中协同作用。

相似文献

1
Synergistic interaction of the Neu proto-oncogene product and transforming growth factor alpha in the mammary epithelium of transgenic mice.Neu原癌基因产物与转化生长因子α在转基因小鼠乳腺上皮中的协同相互作用。
Mol Cell Biol. 1996 Oct;16(10):5726-36. doi: 10.1128/MCB.16.10.5726.
2
Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis.转化生长因子α与c-myc在小鼠乳腺和唾液腺肿瘤发生中的协同相互作用。
Cell Growth Differ. 1995 Jun;6(6):737-48.
3
Blockade of the epidermal growth factor receptor tyrosine kinase suppresses tumorigenesis in MMTV/Neu + MMTV/TGF-alpha bigenic mice.表皮生长因子受体酪氨酸激酶的阻断抑制了MMTV/Neu + MMTV/TGF-α双转基因小鼠的肿瘤发生。
Proc Natl Acad Sci U S A. 2000 Aug 15;97(17):9609-14. doi: 10.1073/pnas.160564197.
4
p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.p130Cas作为乳腺上皮细胞增殖、存活及HER2-neu癌基因依赖性乳腺肿瘤发生的新型调节因子。
Cancer Res. 2006 May 1;66(9):4672-80. doi: 10.1158/0008-5472.CAN-05-2909.
5
Activation of Akt-1 (PKB-alpha) can accelerate ErbB-2-mediated mammary tumorigenesis but suppresses tumor invasion.Akt-1(蛋白激酶Bα)的激活可加速ErbB-2介导的乳腺肿瘤发生,但会抑制肿瘤侵袭。
Cancer Res. 2004 May 1;64(9):3171-8. doi: 10.1158/0008-5472.can-03-3465.
6
Activated neu induces rapid tumor progression.激活的神经上皮细胞诱导肿瘤快速进展。
J Biol Chem. 1996 Mar 29;271(13):7673-8. doi: 10.1074/jbc.271.13.7673.
7
Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease.neu原癌基因在转基因小鼠乳腺上皮中的表达会诱发转移性疾病。
Proc Natl Acad Sci U S A. 1992 Nov 15;89(22):10578-82. doi: 10.1073/pnas.89.22.10578.
8
Inhibition of mammary gland involution is associated with transforming growth factor alpha but not c-myc-induced tumorigenesis in transgenic mice.在转基因小鼠中,乳腺退化的抑制与转化生长因子α有关,但与c-myc诱导的肿瘤发生无关。
Cancer Res. 1995 Sep 1;55(17):3915-27.
9
Treatment with farnesyl-protein transferase inhibitor induces regression of mammary tumors in transforming growth factor (TGF) alpha and TGF alpha/neu transgenic mice by inhibition of mitogenic activity and induction of apoptosis.法尼基蛋白转移酶抑制剂治疗通过抑制促有丝分裂活性和诱导凋亡,使转化生长因子(TGF)α及TGFα/neu转基因小鼠的乳腺肿瘤发生消退。
Clin Cancer Res. 1999 Jan;5(1):35-42.
10
Activation of Src family kinases in Neu-induced mammary tumors correlates with their association with distinct sets of tyrosine phosphorylated proteins in vivo.在Neu诱导的乳腺肿瘤中,Src家族激酶的激活与其在体内与不同酪氨酸磷酸化蛋白组的关联相关。
Oncogene. 1995 Nov 2;11(9):1801-10.

引用本文的文献

1
Epithelial Expressed B7-H4 Drives Differential Immunotherapy Response in Murine and Human Breast Cancer.上皮细胞表达的 B7-H4 驱动了小鼠和人乳腺癌的免疫治疗反应差异。
Cancer Res Commun. 2024 Apr 24;4(4):1120-1134. doi: 10.1158/2767-9764.CRC-23-0468.
2
A Mouse-Specific Model to Detect Genes under Selection in Tumors.一种用于检测肿瘤中受选择基因的小鼠特异性模型。
Cancers (Basel). 2023 Oct 26;15(21):5156. doi: 10.3390/cancers15215156.
3
Mammary gland development and EDC-driven cancer susceptibility in mesenchymal ERα-knockout mice.乳腺发育和 EDC 驱动的间质 ERα 敲除小鼠的癌症易感性。
Endocr Relat Cancer. 2023 Nov 14;30(12). doi: 10.1530/ERC-23-0062. Print 2023 Dec 1.
4
NEDD9 Overexpression Causes Hyperproliferation of Luminal Cells and Cooperates with HER2 Oncogene in Tumor Initiation: A Novel Prognostic Marker in Breast Cancer.NEDD9过表达导致管腔细胞过度增殖并在肿瘤发生过程中与HER2癌基因协同作用:一种乳腺癌的新型预后标志物。
Cancers (Basel). 2023 Feb 9;15(4):1119. doi: 10.3390/cancers15041119.
5
Focal Adhesion Kinase Provides a Collateral Vulnerability That Can Be Leveraged to Improve mTORC1 Inhibitor Efficacy.粘着斑激酶提供了一种可利用的旁系脆弱性,以提高mTORC1抑制剂的疗效。
Cancers (Basel). 2022 Jul 11;14(14):3374. doi: 10.3390/cancers14143374.
6
HSP70s in Breast Cancer: Promoters of Tumorigenesis and Potential Targets/Tools for Therapy.热休克蛋白 70 家族在乳腺癌中的作用:促进肿瘤发生及作为治疗靶点/工具的潜力。
Cells. 2021 Dec 7;10(12):3446. doi: 10.3390/cells10123446.
7
Transgenic mouse models of breast cancer.乳腺癌转基因小鼠模型。
Cancer Lett. 2021 Sep 28;516:73-83. doi: 10.1016/j.canlet.2021.05.027. Epub 2021 Jun 6.
8
Promising potential of [Lu]Lu-DOTA-folate to enhance tumor response to immunotherapy-a preclinical study using a syngeneic breast cancer model.[Lu]Lu-DOTA-叶酸增强肿瘤免疫治疗反应的潜力——使用同源乳腺癌模型的临床前研究。
Eur J Nucl Med Mol Imaging. 2021 Apr;48(4):984-994. doi: 10.1007/s00259-020-05054-9. Epub 2020 Oct 19.
9
Increased susceptibility to mammary carcinogenesis and an opposite trend in endometrium in heterozygous knockout female mice by backcrossing the BALB/c strain onto the background C3H strain.通过将BALB/c品系回交到C3H背景品系上,杂合敲除雌性小鼠对乳腺癌发生的易感性增加,而子宫内膜则呈现相反的趋势。
J Toxicol Pathol. 2019 Jul;32(3):197-203. doi: 10.1293/tox.2018-0057. Epub 2019 Apr 25.
10
Receptor Tyrosine Kinase-Targeted Cancer Therapy.受体酪氨酸激酶靶向癌症治疗。
Int J Mol Sci. 2018 Nov 6;19(11):3491. doi: 10.3390/ijms19113491.

本文引用的文献

1
Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family.表皮生长因子受体家族的第四个成员HER4/p180erbB4的配体特异性激活。
Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1746-50. doi: 10.1073/pnas.90.5.1746.
2
The mouse waved-2 phenotype results from a point mutation in the EGF receptor tyrosine kinase.小鼠waved-2表型是由表皮生长因子受体酪氨酸激酶中的一个点突变引起的。
Genes Dev. 1994 Feb 15;8(4):399-413. doi: 10.1101/gad.8.4.399.
3
Identification of c-erbB-3 binding sites for phosphatidylinositol 3'-kinase and SHC using an EGF receptor/c-erbB-3 chimera.利用表皮生长因子受体/c-erbB-3嵌合体鉴定磷脂酰肌醇3'-激酶和SHC的c-erbB-3结合位点。
EMBO J. 1994 Jun 15;13(12):2831-41. doi: 10.1002/j.1460-2075.1994.tb06577.x.
4
Novel activating mutations in the neu proto-oncogene involved in induction of mammary tumors.参与乳腺肿瘤诱导的neu原癌基因中的新型激活突变。
Mol Cell Biol. 1994 Nov;14(11):7068-77. doi: 10.1128/mcb.14.11.7068-7077.1994.
5
Ligand-like effects induced by anti-c-erbB-2 antibodies do not correlate with and are not required for growth inhibition of human carcinoma cells.抗c-erbB-2抗体诱导的类配体效应与人类癌细胞的生长抑制不相关,且生长抑制并不需要该效应。
Cancer Res. 1994 Mar 1;54(5):1367-73.
6
Mammary tumors expressing the neu proto-oncogene possess elevated c-Src tyrosine kinase activity.表达neu原癌基因的乳腺肿瘤具有升高的c-Src酪氨酸激酶活性。
Mol Cell Biol. 1994 Jan;14(1):735-43. doi: 10.1128/mcb.14.1.735-743.1994.
7
Direct and specific interaction of c-Src with Neu is involved in signaling by the epidermal growth factor receptor.c-Src与Neu的直接特异性相互作用参与表皮生长因子受体的信号传导。
Oncogene. 1995 Jul 20;11(2):271-9.
8
A mutation in the epidermal growth factor receptor in waved-2 mice has a profound effect on receptor biochemistry that results in impaired lactation.波发-2小鼠表皮生长因子受体的突变对受体生物化学有深远影响,导致泌乳受损。
Proc Natl Acad Sci U S A. 1995 Feb 28;92(5):1465-9. doi: 10.1073/pnas.92.5.1465.
9
ErbB3 is involved in activation of phosphatidylinositol 3-kinase by epidermal growth factor.ErbB3参与表皮生长因子对磷脂酰肌醇3激酶的激活过程。
Mol Cell Biol. 1994 Jun;14(6):3550-8. doi: 10.1128/mcb.14.6.3550-3558.1994.
10
Monoclonal antibodies identify a cell-surface antigen associated with an activated cellular oncogene.单克隆抗体识别一种与活化细胞癌基因相关的细胞表面抗原。
Nature. 1984;312(5994):545-8. doi: 10.1038/312545a0.